- Phase I trial of granulocyte-macrophage colony-stimulating factor with high-dose cisplatin and etoposide for treatment of small-cell lung cancer: a study of the National Cancer Institute of Canada Clinical Trials Group. Shepherd, F.A., Goss, P.E., Rusthoven, J., Eisenhauer, E.A. J. Natl. Cancer Inst. (1992)